Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$71.58 - $87.29 $134,856 - $164,454
-1,884 Reduced 40.57%
2,760 $202,000
Q4 2023

Feb 14, 2024

SELL
$73.27 - $83.09 $5,934 - $6,730
-81 Reduced 1.71%
4,644 $376,000
Q3 2023

Nov 01, 2023

BUY
$73.94 - $80.67 $46,951 - $51,225
635 Added 15.53%
4,725 $354,000
Q2 2023

Aug 07, 2023

SELL
$76.01 - $86.7 $35,420 - $40,402
-466 Reduced 10.23%
4,090 $315,000
Q1 2023

May 03, 2023

SELL
$77.31 - $88.08 $6,880 - $7,839
-89 Reduced 1.92%
4,556 $378,000
Q4 2022

Feb 07, 2023

SELL
$62.32 - $89.47 $73,350 - $105,306
-1,177 Reduced 20.22%
4,645 $398,000
Q3 2022

Nov 01, 2022

SELL
$59.54 - $68.01 $3,036 - $3,468
-51 Reduced 0.87%
5,822 $359,000
Q2 2022

Jul 26, 2022

BUY
$57.72 - $65.01 $33,362 - $37,575
578 Added 10.92%
5,873 $363,000
Q1 2022

Apr 14, 2022

BUY
$57.92 - $72.58 $65,044 - $81,507
1,123 Added 26.92%
5,295 $315,000
Q4 2021

Jan 28, 2022

SELL
$64.88 - $73.64 $17,971 - $20,398
-277 Reduced 6.23%
4,172 $303,000
Q3 2021

Nov 04, 2021

BUY
$67.69 - $73.03 $18,547 - $20,010
274 Added 6.56%
4,449 $311,000
Q2 2021

Jul 19, 2021

BUY
$63.47 - $69.35 $10,853 - $11,858
171 Added 4.27%
4,175 $287,000
Q1 2021

May 17, 2021

BUY
$60.0 - $68.46 $240,240 - $274,113
4,004 New
4,004 $259,000
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $261,660 - $298,554
-4,361 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $247,050 - $281,502
4,361 New
4,361 $254,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Woodward Diversified Capital, LLC Portfolio

Follow Woodward Diversified Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodward Diversified Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Woodward Diversified Capital, LLC with notifications on news.